Product
CYP 450 Substrates
1 clinical trial
1 indication
Indication
Atopic DermatitisClinical trial
An Open-label Drug-Drug Interaction Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Subjects With Moderate-to-Severe Atopic DermatitisStatus: Completed, Estimated PCD: 2023-06-07